NIKKEI Drug Discovery Ecosystem Summit

Fumio Kishida

Member of the House of the Representatives

Hideki Murai

Member of the House of the Representatives

Akihisa Shiozaki

Member of the House of the Representatives

Kazuto Ihara

Vice-Minister of Health, Labour and Welfare

Kenichiro Watanabe

Director, National Healthcare Policy Secretariat, Cabinet Office

Rami Suzuki

Representative Director CEO, ARC Therapies Inc.

Shinichiro Fuse

TPG Life Sciences Innovations
Partner and Managing Director

Dan Kemp

CEO, Shinobi Therapeutics, Inc.

Mikkel Skovborg

Senior Vice President, Innovation, Novo Nordisk Foundation,

Akihiko Soyama

CEO, Life Science Innovation Network Japan / Specially Appointed Professor, Tohoku University

John Paul Pullicino

President and Representative Director, Novartis Pharma K.K.

Fumiaki Ikeno

Researcher, Stanford University

Kazumasa Oguro

Professor, Faculty of Economics, Hosei University

Masato Iwasaki

Senior Executive Fellow, IGPI Group, Inc.

Yasuko Shoji

Manager, Research Unit
Medical & Healthcare Institute, Nikkei BP Intelligence Group, Nikkei Business Publications, Inc.

Tadayoshi Mizutani

Director, Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, Health Policy Bureau, Ministry of Health, Labour and Welfare

Masaaki Miyakawa

Executive Board Member, Japan Medical Association

Hitoshi Kuboniwa

Japan Bioindustry Association,Chairman Steering Committee

Yukiko Nishimura

NPO ASrid, President

Yasuhiro Fujiwara

Chief Executive, Pharmaceuticals and Medical Devices Agency

Yuji Kashitani

Executive Director, Global Regulatory Policy & Innovation Japan, Takeda Development Center Japan

Masanobu Saito

Corporate Officer, Head of Value & Access, Japan, Novartis Pharma K.K.

Masahisa Jinushi

Executive Direcotr, Head of Medical Affairs, Gilead Sciences K.K.

Shintaro Sengoku

Professor, School of Environment and Society, Institute of Science Tokyo

Hirokazu Shimoda

Director, Bio-Industry Division, Commerce and Service Industry Policy Group, Ministry of Economy, Trade and Industry

Yoshiki Sawa

President,Organization of Future Medicine

Toshio Fujimoto

Chief Executive Officer, iPark Institute Co., Ltd.

Yusaku Katada

Restore Vision Inc. CEO

Morten Sogaard

Head, Innovation Lab, Astellas Pharma

Hiroo Igarashi

President & Representative Director, Pfizer Japan Inc.

Masamitsu Harata

Chairman, CEO and Founder at Human Life CORD Japan Inc.

Koutaro Yokote

President, Japan Society for the Study of Obesity/ President, Chiba University

Ataru Igarashi

Associate Professor, Dept. of Public Health and Health Policy, Graduate School of Pharmaceutical Sciences, The University of Tokyo

Gaku Hashimoto

Professor, Faculty of Health and Welfare Services Administration, Kawasaki University of Medical Welfare（Former Member of the House of Representatives）

Wataru Sugiura

Director General, Center for Clinical Science, Japan Institute for Health Security

Hiroto Araki

Director, Infectious Diseases Control Division, Ministry of Health, Labour and Welfare

Kennet Brysting

President and Representative Director of Gilead Sciences K.K.

Toshihiko Takeda

Senior Advisor, Boston Consulting Group

Kanae Kurata

Director, Life Sciences Division, Research Promotion Bureau, Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Shin Kaneko

Professor, Center for iPS Cell and Research Application, Kyoto University

Kiyohumi Kaneshiro

Chief Financial Officer, PeptiDream Inc.

Takeyuki Akiyama

Director, Japan Alliance for Lysosomal Disease Patient Organizations

Shinichiro Komoto

Eight Roads Ventures Japan・Partner

Hiroshi Miyake

Chief Executive Officer, Chordia Therapeutics

Aya Kubota

Editor in Chief, Nikkei Biotechnology & Business, Nikkei Business Publications, Inc.

Jin Shiomura

Founder, Managing Director & CEO of Nobelpharma

Sumito Nishidate

Chairman of the GIST & Sarcoma Patients and Families Association "NPO GISTERS"

Kazuhiko Mori

Senior Managing Director of Japan Pharmaceutical Manufacturers Association

Masami Sakoi

Chief Medical and Global Health Officer of Ministry of Health, Labour and Welfare

Asuka Miyabashira

President of Japan Pharmaceutical Manufacturers Association

Yasushi Okuno

Professor, Department of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University

Akira Izumi

CEO & Founder, RyuWell Co.,LTD

Hidenobu Ishizaki

Executive director, Center for Development of Advanced Cancer Therapy, Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR)

Hiroyoshi Toyoshiba

Director/ Chief Technology Officer

Hiroyuki Tsunoda

Deputy Head of Research Division, Chugai Pharmaceutical Co., Ltd.

Masanori Shindo

Deputy General Manager, Life Intelligence Consortium general incorporated association

Sarah Brennan

Company Group Chairman, Global Commercial Strategy Organization, for Johnson & Johnson Innovative Medicine

Takahiko Iwaya

Chair of European Federation of Pharmaceutical Industries and Associations, Japan (EFPIA Japan)

Hans Klemm

Japan Representative, Pharmaceutical Research and Manufacturers of America (PhRMA)

Hitoshi Nakagama

Japan Agency for Medical Research and Development/President

Kazuto Yamada

President and CEO, Japan Tissue Engineering Co., Ltd.

Kiyoshi Ando

Senior Staff Writer, Nikkei Inc.